We also uncovered that the synthesis of aberrant PIK3CD-S splice variant is likely mediated by the splicing factor SRSF2, and inhibition of SRSF2 by SRPK1/2 inhibitor SRPIN340 significantly sensitizes AA PCa to Idelalisib (33). The gene discussed is PIK3CD; the disease is posterior cortical atrophy.